Therefore, the effects of Cyn were assessed on two patient-derived glioblastoma cell lines, NULU and ZAR, genetically characterized by IDH1/2 wild-type and unmethylated MGMT gene promoter, thus by a TMZ-resistant phenotype. Here, MGMT is linked to glioblastoma.